Evidence map›Paper›PMID 41969815›Full record

ArticleRheumatology and immunology research2026

Community-based epidemiological study on the prevalence and health status of Spondyloarthritis in residents of Wuyuan County, China, 2023.

Shichao Yu, Xiuling Zhang, Zhijie Liu, Dunwu Wu, Yuanjia Pan, Jinying Wang, Jinghong Li, Libo Zha, Yumin Dong, Senmiao Zhang and 7 more

Abstract read
In one paragraph

Article in Rheumatology and immunology research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Shichao YuDepartment of Rheumatology and Immunology, Wuyuan County Maternal and Child Health Hospital, Shangrao 333200, Jiangxi Province, China.
Xiuling ZhangDepartment of Rheumatology and Immunology, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, Jiangxi Province, China.
Zhijie LiuDepartment of Rheumatology and Immunology, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, Jiangxi Province, China.
Dunwu WuDepartment of Rheumatology and Immunology, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, Jiangxi Province, China.
Yuanjia PanDepartment of Rheumatology and Immunology, Wuyuan County Maternal and Child Health Hospital, Shangrao 333200, Jiangxi Province, China.
Jinying WangDepartment of Rheumatology and Immunology, Wuyuan County Maternal and Child Health Hospital, Shangrao 333200, Jiangxi Province, China.
Jinghong LiDepartment of Rheumatology and Immunology, Wuyuan County Maternal and Child Health Hospital, Shangrao 333200, Jiangxi Province, China.
Libo ZhaDepartment of Rheumatology and Immunology, Wuyuan County Maternal and Child Health Hospital, Shangrao 333200, Jiangxi Province, China.
Yumin DongDepartment of Rheumatology and Immunology, Wuyuan County Maternal and Child Health Hospital, Shangrao 333200, Jiangxi Province, China.
Senmiao ZhangTuochuan Township Health Center, Wuyuan County, Shangrao 333200, Jiangxi Province, China.
Guoliang WuTaibai Town Health Center, Wuyuan County, Shangrao 333200, Jiangxi Province, China.
Zhongpei WangDuanxin Township Health Center, Wuyuan County, Shangrao 333200, Jiangxi Province, China.
Guixing DongZhentou Town Health Center, Wuyuan County, Shangrao 333200, Jiangxi Province, China.
Junbo ZhuQiukou Central Health Center, Wuyuan County, Shangrao 333200, Jiangxi Province, China.
Nan WangDepartment of Rheumatology and Immunology, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, Jiangxi Province, China.
Xinwang DuanDepartment of Rheumatology and Immunology, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, Jiangxi Province, China.ORCID https://orcid.org/0000-0002-0432-3638
Zhirao HuangDepartment of Rheumatology and Immunology, Wuyuan County Maternal and Child Health Hospital, Shangrao 333200, Jiangxi Province, China.ORCID https://orcid.org/0009-0005-7275-2708

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Objective: The prevalence of Spondyloarthritis (SpA) in China is approximately 1%, with ankylosing spondylitis (AS) at 0.25%. However, community-based incidence data remain scarce and are subject to medical reporting bias. This study aimed to investigate the prevalence of SpA and the health status of patients in Wuyuan County, to provide evidence for the national "Rural Health Project for Ankylosing Spondylitis". Methods: A cross-sectional survey was conducted from August to December 2023 using the WHO COPCORD methodology. A multi-stage stratified random cluster sampling method was employed, including 16, 996 residents. A screening questionnaire based on assessment of Spondyloarthritis international society (ASAS) criteria was used, and SpA diagnoses were confirmed by rheumatologists. Data analysis included Poisson distribution sample size estimation, Mann-Whitney Results: The estimated prevalence of SpA among residents of Wuyuan County in 2023 was 0.14%. A total of 24 patients were diagnosed with SpA (16 males and 8 females). Half of these cases were previously undiagnosed and demonstrated a significant diagnostic delay ( Conclusion: Community screening revealed a significant burden of SpA in rural China, underscoring the need to strengthen primary healthcare resource allocation.

Indexed as

epidemiological investigationhealth statusprevalencespondyloarthritis

Identifiers

PMID41969815
PMCPMC13066663

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.